Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach - 04/11/20
, Pui Y. Lee, MD, PhD a, b, Hal M. Hoffman, MD cAbstract |
Autoinflammatory diseases are conditions in which pathogenic inflammation arises primarily through antigen-independent hyperactivation of immune pathways. First recognized just over 2 decades ago, the autoinflammatory disease spectrum has expanded rapidly to include more than 40 distinct monogenic conditions. Related mechanisms contribute to common conditions such as gout and cardiovascular disease. Here, we review the basic concepts underlying the “autoinflammatory revolution” in the understanding of immune-mediated disease and introduce major categories of monogenic autoinflammatory disorders recognized to date, including inflammasomopathies and other IL-1–related conditions, interferonopathies, and disorders of nuclear factor kappa B and/or aberrant TNF activity. We highlight phenotypic presentation as a reflection of pathogenesis and outline a practical approach to the evaluation of patients with suspected autoinflammation.
Le texte complet de cet article est disponible en PDF.Key words : Autoinflammation, innate immunity, inflammasome, IFN, NF-κB
Abbreviations used : AGS, AR, CAPS, COPA, DITRA, FMF, HA20, JAK, JAKinhibs, MKD, NF-κB, PFAPA, PLAID, PRAAS, STING, TRAPS, USP18
Plan
| P.A.N. is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (award nos. 2R01AR065538, R01AR075906, R01AR073201, P30AR070253, and R21AR076630) and the National Heart, Lung, and Blood Institute (award no. R21HL150575), the Fundación Bechara, and the Arbuckle Family Fund for Arthritis Research. P.Y.L. is supported by the NIAMS (grant no. K08-AR074562), a Rheumatology Research Foundation Investigator Award, and a Boston Children’s Hospital Faculty Career Development Award. H.M.H. is funded by the National Institutes of Health (award nos. R01 DK113592, R01 HL140898, and R01 R01AI134030) and a UC collaborative grant. |
Vol 146 - N° 5
P. 925-937 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
